학술논문
Outcomes of BCMA-Directed Chimeric Antigen Receptor T-Cell (CART) Therapy and Teclistamab in Patients with Relapse-Refractory Multiple Myeloma with Extramedullary Disease: A Real-World Experience of the US Myeloma Innovations Research Collaborative (USMIRC)
Document Type
Abstract
Author
Dima, Danai; Davis, James; Ahmed, Nausheen; Sannareddy, Aishwarya; Shaikh, Hira; Shune, Leyla; Kaur, Gurbakhash; Khouri, Jack; Afrough, Aimaz; Strouse, Christopher Sun; Lochner, Jonathan; Mahmoudjafari, Zahra; Raza, Shahzad; Valent, Jason; Anderson, Larry D., Jr.; Anwer, Faiz; Hashmi, Hamza; Abdallah, Al-Ola
Source
In Transplantation and Cellular Therapy February 2024 30(2) Supplement:S384-S385
Subject
Language
ISSN
2666-6367